EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis

Haley Belt, Evbu O Enakpene, Judy L Jensen, Alice P Moe, Holly Carveth, Barbara C Cahill, Nathan Hatton, Theodore G Liou, Anwar Tandar

Respiration · 2024

DOI: 10.1159/000541892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiration, 2024. Verfasst von Haley Belt und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Cystic Fibrosis, Hypoxia, Oxygen Inhalation Therapy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patent foramen ovale (PFO) affects about 25% of the population. We studied outcomes in cystic fibrosis (CF).

Methods

We conducted a case-control study of patients with CF (PwCF) and age- and sex-matched controls who underwent agitated saline contrast (bubble) echocardiography, 1998–2020. We assessed PFO impacts using linear, logistic, quasi-Poisson, and Cox proportional hazards models.

Result

Fifty-nine of 64 PwCF and 88 of 93 controls underwent bubble studies to investigate unexplained hypoxemia or dyspnea. PwCF had higher mean pulmonary artery pressure (PAP: 6.9 mm Hg, 95% confidence interval [CI] = 2.35–11.4), reduced tricuspid annular plane systolic excursion (TAPSE: −3.78 mm, CI = −5.64 to −1.93) and similar right ventricular diastolic sizes. Without hypoxemia, the PFO incidence was similar between PwCF and controls; with hypoxemia, PFO was more common in CF (odds ratio = 5.00, CI = 1.32–19.0). In CF, oxygen supplementation occurred at a percent-predicted forced expiratory volume in 1 s (FEV1%), 22.5 points higher with PFO. Adjusted for FEV1%, PFO was associated with 0.59 more prior-year pulmonary exacerbations (CI = 0.20–0.98) and shorter time to next exacerbation (hazard ratio = 1.86, CI = 1.06–3.26). Associations between PFO and hypoxemia or exacerbations were insensitive to PAP, TAPSE, and CF transmembrane regulator protein modulator treatments. PFO was not associated with CF time to death or lung transplantation (median 1.87 years) adjusted for age, sex, FEV1%, and prior-year exacerbation counts.

Conclusion

PFO in CF is associated with hypoxemia at higher FEV1% and more pulmonary exacerbations but not survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Foramen Ovale, PatentCystic FibrosisHypoxiaOxygen Inhalation TherapyHumansFemaleMaleCase-Control StudiesAdultEchocardiographyYoung AdultProportional Hazards Models

Stichwörter der Autor:innen

CFTR modulatorCystic fibrosisHypoxemiaLung functionPatent foramen ovalePulmonary exacerbationSurvival

Autor:innen und Institutionen

  • The Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA.
  • The Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah, USA.
  • The Adult Cystic Fibrosis Center, University of Utah, Salt Lake City, Utah, USA.
  • The Center for Quantitative Biology, University of Utah, Salt Lake City, Utah, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Belt, H., Enakpene, E. O., Jensen, J. L., Moe, A. P., Carveth, H., Cahill, B. C., Hatton, N., Liou, T. G., & Tandar, A. (2024). Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis. Respiration. https://doi.org/10.1159/000541892

Vancouver

Belt H, Enakpene EO, Jensen JL, Moe AP, Carveth H, Cahill BC, et al. Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis. Respiration. 2024. doi:10.1159/000541892

BibTeX
@article{Belt2024,
  author = {Belt, Haley and Enakpene, Evbu O and Jensen, Judy L and Moe, Alice P and Carveth, Holly and Cahill, Barbara C and Hatton, Nathan and Liou, Theodore G and Tandar, Anwar},
  title = {Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis},
  journal = {Respiration},
  year = {2024},
  doi = {10.1159/000541892}
}
Kostenlos starten →